Patient First Maryland Medical Group PLLC
Patient First Maryland Medical Group PLLC was paid $3.12M by Medicaid between Dec 2018 and Dec 2024, across 36 billing codes. Its largest line is S9083, Global fee urgent care centers — 55% of everything it billed.
BOWIE, MD 20715
Next to other Urgent Care Clinic/Center providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14 | $130.00 | |
| 2019 | 148 | $1K | |
| 2020 | 3,857 | $251K | |
| 2021 | 10,849 | $615K | |
| 2022 | 16,774 | $711K | |
| 2023 | 19,189 | $785K | |
| 2024incomplete | 17,744 | $756K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 55% | 13,027 | 11,123 | $1.72M |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 21% | 5,819 | 5,359 | $643K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 7,538 | 6,613 | $266K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.3% | 5,916 | 5,412 | $229K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 2,146 | 2,033 | $89K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 2,148 | 1,916 | $83K |
| 87428 | 1.3% | 4,768 | 3,929 | $40K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 3,293 | 3,056 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 565 | 508 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 412 | 380 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,686 | 4,968 | $2K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 13 | 13 | $1K |
24 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,834 | $1K |
| 99058 | <1% | 125 | $1K | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 149 | $1K |
| 81000 | <1% | 1,870 | $719.39 | |
| 80047 | <1% | 1,660 | $689.21 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,080 | $603.41 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,111 | $483.60 |
| 90686 | <1% | 35 | $457.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,296 | $371.04 |
| 81002 | <1% | 1,799 | $319.91 | |
| 86580 | <1% | 15 | $236.40 | |
| 93000 | <1% | 450 | $199.81 | |
| 99201 | <1% | 28 | $93.30 | |
| 73564 | <1% | 46 | $89.37 | |
| 73610 | <1% | 70 | $82.21 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 236 | $68.65 |
| 81025 | <1% | 743 | $58.90 | |
| 87210 | <1% | 711 | $37.70 | |
| 87220 | <1% | 743 | $31.67 | |
| 73140 | <1% | 12 | $25.19 | |
| 99051 | 0% | 123 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 19 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 47 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.